Navigation Links
Promising treatment for metastatic melanoma 'fast tracked' by FDA
Date:9/9/2010

HACKENSACK, N.J. (September 9, 2010) Researchers from the John Theurer Cancer Center at Hackensack University Medical Center played an important role in a study that led to the Food & Drug Administration's (FDA) recent fast tracking of ipilimumab, a promising treatment for metastatic melanoma. The FDA based its decision largely on the results of a pivotal study published in the New England Journal of Medicine on August 19, 2010 the same day the agency accepted Bristol-Myers Squibb's application for the drug's approval and granted the application priority review status.

Ipilimumab is the first drug shown in randomized, placebo-controlled trials to improve survival in stage IV melanoma.

"This study, and the FDA's decision, provides new hope for people with this devastating cancer," said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., Chairman and Executive Administrative Director, John Theurer Cancer Center, who led the study at the John Theurer Cancer Center. "We are proud to have played a role in helping move another promising cancer treatment closer to market."

The incidence of metastatic melanoma has increased over the last three decades, and the death rate continues to climb faster than that of most other cancers. According to the American Cancer Society, there were approximately 68,000 new cases of melanoma in the United States in 2009, and 8,700 melanoma-related deaths. Melanoma accounts for about three percent of all skin cancers, but 80 percent of skin cancer deaths. Melanoma is difficult to treat once it has spread beyond the skin to other parts of the body (metastasized). Very few treatment options exist for people with metastatic melanoma.

In this phase III study, researchers randomly assigned patients to one of three treatment groups: those receiving ipilimumab plus an inactive (placebo) version of gp 100, a cancer vaccine; those receiving ipilimumab plus gp 100; and those receiving gp 100 plus ipilimumab placebo. The trea
'/>"/>

Contact: Amy Leahing
amy.leahing@widmeyer.com
646-213-7245
John Theurer Cancer Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
2. First blinded study of venous insufficiency prevalence in MS shows promising results
3. Promising therapy for relapsing multibple sclerosis
4. New strategy produces promising advance in cancer vaccines
5. Sytropin HGH Shows Promising Anti-Aging Results
6. Lacosamide validated as promising therapy for uncontrolled partial-onset seizures
7. New smoking cessation therapy proves promising
8. SBRT eliminates tumors with promising survival for early-stage inoperable lung cancer patients
9. Promising strategy for treatment of lung cancer
10. McMaster researcher leads development of promising drug for inflammation
11. Promising hormone may help reduce malnutrition in gastric cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015 The City of West Hollywood hosted a ... commemorate the 42nd anniversary of the Supreme Court decision Roe v. ... 42 years since the Roe vs. Wade decision and the fight ... as ever,” said City of West Hollywood Councilmember Abbe Land. “We ...
(Date:1/22/2015)... Chemo Duck Program is pleased to announce the release of the ... with cancer. The Chemo Duck App, available on iTunes for use ... to help children of all ages living with cancer adjust to ... entertained, educated and at ease while waiting for clinic visits or ...
(Date:1/22/2015)... a seasoned and trusted leader who consistently delivers trendy dresses ... it lead the wedding dress industry into the future. Today, ... the global market. , “The CEO of VogueQueen is uniquely ... continuing the goal of operational excellence and giving back to ...
(Date:1/22/2015)... 23, 2015 Angelweddingdress is a famous wedding ... its customers to follow it on Facebook, Twitter, and Pinterest. ... Day gift. Angelweddingdress draws a lottery every week. , Moreover, ... Feb. 28, 2015. Click Angelweddingdress homepage for more ...
(Date:1/22/2015)... 2015 AngelWeddingDress, the premier women’s dress ... wedding dresses. View website of AngelWeddingDress.com to ... maternity wedding dresses online for a bridal party. AngelWeddingDress ... quality for them. Its maternity wedding dresses are specially ...
Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2
... regional pain syndrome is a neurological disorder caused by continuous ... sense pain. // ,This syndrome includes all the post-traumatic ... injury has healed. But the causes of the symptoms of ... the fact that there are very few objective findings, diagnosis ...
... British Prime Minister Tony Blair today formally inducted 11 private ... further step towards increasing competition in the health sector. //Mr ... members at a summit held at Downing Street to mark ... signed a document pledging to work as partners towards 'future ...
... is the key to weight loss a new study says ... //, ,This study comes from the Canadian Institute for ... work can help make or break our battle against the ... CIHI's Canadian Population Health Initiative, "We see that the majority ...
... pollution in the air now that if it weren't for ... -Robert Orben // ,The order of the ... Clemenceau to be sent back to France, represents the overall ... The order has been issued following dismissal of the proposed ...
... profound impact on either couple, men seem to be more ... Christakis and his research team from Harvard Medical School. ... spouse on the risk of illness in the other partner ... elderly couples. ,They found that when a spouse ...
... at the Washington Hospital Center studied the use of ... blocked arteries. // ,These blocked arteries are ... as it leads to devastating complications such as amputation. ... high blood pressure are at high risk for losing ...
Cached Medicine News:Health News:Location largely affects weight 2Health News:The Return Of The Clemenceau: Happy India 2Health News:Laser Used To Clear Blocked Arteries Preventing Amputation, 2
(Date:1/23/2015)...  Mallinckrodt plc (NYSE: MNK ) announced today ... repurchase program. The open-ended authorization permits the company to ... shares. "Funding additional initiatives and seeking ... continue to pursue a range of focused growth strategies," ...
(Date:1/22/2015)... 22, 2015  BiOptix is pleased to announce the appointment ... of Chemistry and Biochemistry. Scott joins the company after previous ... Amgen throughout the course of his nearly 20 year ... is a nationally recognized thought leader in the biosensor ...
(Date:1/22/2015)... 2015  Bio-Techne Corporation (NASDAQ: TECH ) announced ... of the new Simple Plex platform through its Proteins ... the re-branding of the previously acquired CyPlex instrument platform ... a transformative immunoassay technology which integrates an innovatively designed ...
Breaking Medicine Technology:Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2Bio-Techne Launches Simple Plex Platform 2Bio-Techne Launches Simple Plex Platform 3
... Sept. 15 VentiRx Pharmaceuticals, Inc., a biopharmaceutical company ... (TLR8) candidates for the treatment of cancer, respiratory and ... to the annual FierceBiotech "Fierce 15" list, designating it ... companies in the industry. Every year, FierceBiotech evaluates hundreds ...
... (Nasdaq: CYPB )  ("Cypress") today confirmed that Ramius ... all outstanding common shares of Cypress at a price of ... fiduciary duties and as required by applicable law, the Cypress ... course of action that it believes is in the best ...
Cached Medicine Technology:FierceBiotech Names VentiRx Pharmaceuticals as One of the 'Fierce 15' Biotech Companies of 2010 2Cypress Bioscience Board of Directors to Review Unsolicited Tender Offer from Ramius LLC 2
... II Smart ValveTM, Hakim, H-V ... intelligent choice for meeting the ... Automatic pressure response causes the ... the conditions present, eliminating the ...
Codman Hakim Programmable valve cylindrical offers the ability to optimize the opening pressure of a shunt system before and after implantation. A shunted patient's condition will often change over t...
Leadpoint Micro-Electrode Recording...
... Using advanced 3D matching algorithms developed by ... automatically merges image sets from a variety ... PET, regardless of acquisition orientation. Stealthmerge even ... the requirement to scan tissue outside the ...
Medicine Products: